International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8110795
Original Article
Prevalance of Psychiatric Morbidity in the Primary Caregivers of Individuals on Dialysis for End Stage Renal Disease – A Cross Sectional Study
 ,
Published
July 3, 2023
Abstract

Background & Objectives: Family caregivers are considered as hidden patients experiencing physical and mental disorders. This affects the quality of not only their lives but also the health care provided to patients. This study aimed to investigate the psychiatric morbidity and its related factors among the caregivers of patients undergoing hemodialysis.

Methods: 30 consecutive caregivers of dialysis patients attending the dialysis unit in department of Nephrology were included. Socio-demographic data of both patients and caregivers was obtained using a semi structured proforma. Psychiatric morbidity was assessed using Mini-International Neuropsychiatric Interview (MINI).

Results: Majority of the caregivers were less than 60 years of age, females, literates, employed, were related as spouses of patients followed by children. 93.3 % of caregivers had psychiatric morbidity most common being major depressive disorder (43.4%).

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
787 Views
99 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved